Thyrocare Technologies informs about disclosure

20 Feb 2021 Evaluate

Thyrocare Technologies has informed that pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company is filing the transcript of the Earnings Call held on Thursday, February 04, 2021 at 05.00 pm local time, post declaration of the Company’s unaudited financial results (Stand-alone and Consolidated) for Quarter/ Nine Months ended December 31, 2020. This transcript is also made available at its website. A. Velumani, Chairman & Managing Director; Arindam Haldar, CEO; A. Sundararaju, CFO & Executive Director; Sachin Salvi, Vice-President- Finance, represented the Company.

The above information is a part of company’s filings submitted to BSE.

Thyrocare Tech. Share Price

922.20 -26.85 (-2.83%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7000.00
Max Healthcare Inst 1008.35
Narayana Hrudayalay 1265.30
Aster DM Healthcare 442.70
Global Health 1105.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.